Search results for "Amnesia"

showing 10 items of 54 documents

Hypericum Extract and Hyperforin: Memory-Enhancing Properties in Rodents

2001

Effects of a Hypericum extract in therapeutic use and hyperforin sodium salt were evaluated in rat and mouse avoidance tests. In a conditioned avoidance response (CAR) test on the rat, oral daily administration of hyperforin (1.25 mg/kg/day) or of the extract (50 mg/kg/day) before the training sessions considerably improved learning ability from the second day onwards until the day 7. In addition, the memory of the learned responses acquired during 7 consecutive days of administration and training was largely retained even after 9 days without further treatment or training. The observations made using different doses indicate that these learning-facilitating and/or memory-consolidating effe…

MaleStereochemistryScopolamineAmnesiaMuscarinic AntagonistsPhloroglucinolPharmacologyAvoidance responseBridged Bicyclo CompoundsMicechemistry.chemical_compoundMemoryOral administrationAvoidance LearningAnimalsMedicinePharmacology (medical)Rats WistarMice Inbred BALB CBehavior AnimalbiologyPlant ExtractsTerpenesbusiness.industryHypericum perforatumGeneral Medicinebiology.organism_classificationEffective dose (pharmacology)Antidepressive AgentsRatsPsychiatry and Mental healthHyperforinchemistryAntidepressantAmnesiamedicine.symptombusinessHypericumHypericumPharmacopsychiatry
researchProduct

Selective sparing of face learning in a global amnesic patient

2001

Objective - To test the hypothesis that visual memory for faces can be dissociated from visual memory for topographical material. Method - A patient who developed a global amnesic syndrome after acute carbon monoxide poisoning is described. A neuroradiological examination documented severe bilateral atrophy of the hippocampi. Results - Despite a severe anterograde memory disorder involving verbal information, abstract figures, concrete objects, topographical scenes, and spatial information, the patient was still able to learn previously unknown human faces at a normal (and, in some cases, at a higher) rate. Conclusions - Together with previous neuropsychological evidence documenting selecti…

Malegenetic structuresAmnesiaNeurological disorderNeuropsychological TestsHippocampusSeverity of Illness IndexCarbon Monoxide PoisoningAtrophyHippocampuVisual memorySeverity of Illness Index; Acute Disease; Magnetic Resonance Imaging; Hippocampus; Carbon Monoxide Poisoning; Humans; Neurologic Examination; Prosopagnosia; Case-Control Studies; Atrophy; Middle Aged; Neuropsychological Tests; Amnesia; MaleAmnesia; Face learning; Acute Disease; Amnesia; Atrophy; Carbon Monoxide Poisoning; Case-Control Studies; Hippocampus; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neurologic Examination; Neuropsychological Tests; Prosopagnosia; Severity of Illness IndexmedicineFace learningDementiaHumansMemory disorderNeurologic ExaminationSettore M-PSI/02 - Psicobiologia E Psicologia FisiologicaNeuropsychologyCognitionMiddle Agedmedicine.diseaseMagnetic Resonance ImagingPsychiatry and Mental healthProsopagnosiaCase-Control StudiesPapersAcute DiseaseSettore MED/26 - NeurologiaSurgeryNeuropsychological TestNeurology (clinical)Amnesiamedicine.symptomAtrophyPsychologyCase-Control StudieNeuroscienceHuman
researchProduct

Preclinical dementia: an Italian multicentre study on amnestic mild cognitive impairment

2006

<i>Background:</i> Different rates and cognitive predictors of conversion to dementia have been reported in subjects with different kinds of mild cognitive impairment (MCI). <i>Methods:</i> A prospective, 24-month follow-up study, involving 269 subjects who strictly fulfilled criteria for the amnestic MCI. <i>Results:</i> Conversion rate to dementia was 21.4% per year. Seventy-nine out of the 83 individuals who developed dementia were affected by probable Alzheimer’s disease (AD). Among others, at the 24-month follow-up 24.1% were still affected by amnestic MCI, 13.3% had changed their neuropsychological profile of impairment and 17.2% were cognitively no…

Malemedicine.medical_specialtyClinical Dementia RatingCognitive NeuroscienceAudiologyPattern RecognitionNeuropsychological TestsCohort StudiesAlzheimer DiseasePredictive Value of TestsAlzheimer's disease Dementia Mild cognitive impairment NeurospychologymedicineDementiaMemory impairmentHumansMemory disorderProspective StudiesPsychiatryHumans; Alzheimer Disease; Disease Progression; Aged; Predictive Value of Tests; Cognition Disorders; Italy; Verbal Learning; Prospective Studies; Pattern Recognition Visual; Cohort Studies; Follow-Up Studies; Dementia; Neuropsychological Tests; Amnesia; Female; MaleAgedAlzheimer’s disease Mild cognitive impairment Dementia NeurospychologyCognitive disorderNeuropsychologyMild cognitive impairmentCognitionVerbal LearningAlzheimer's diseaseNeurospychologymedicine.diseasePsychiatry and Mental healthPattern Recognition VisualItalyDisease ProgressionFemaleSettore MED/26 - NeurologiaDementiaAmnesiaGeriatrics and GerontologyAlzheimer's diseasePsychologyCognition DisordersVisualFollow-Up Studies
researchProduct

Carnitine congener mildronate protects against stress- and haloperidol-induced impairment in memory and brain protein expression in rats.

2014

The present study investigates the efficacy of mildronate, a carnitine congener, to protect stress and haloperidol-induced impairment of memory in rats and the expression of brain protein biomarkers involved in synaptic plasticity, such as brain-derived neurotrophic factor (BDNF), acetylcholine esterase and glutamate decarboxylase 67 (GAD67). Two amnesia models were used: 2h immobilization stress and 3-week haloperidol treatment. Stress caused memory impairment in the passive avoidance test and induced a significant 2-fold BDNF elevation in hippocampal and striatal tissues that was completely inhibited by mildronate. Mildronate decreased the level of GAD67 (but not acetylcholine esterase) e…

Malemedicine.medical_specialtyGlutamate decarboxylaseAmnesiaNerve Tissue ProteinsHippocampal formationGPI-Linked ProteinsNeurotrophic factorsMemoryStress PhysiologicalInternal medicineCarnitinemedicineHaloperidolAvoidance LearningMemory impairmentAnimalsCarnitineRats WistarMaze LearningPharmacologyChemistryGlutamate DecarboxylaseBrain-Derived Neurotrophic FactorBrainRatsEndocrinologyNeuroprotective AgentsSynaptic plasticityAcetylcholinesteraseHaloperidolmedicine.symptomNeuroscienceBiomarkersmedicine.drugMethylhydrazinesEuropean journal of pharmacology
researchProduct

Movements Execution in Amnestic Mild Cognitive Impairment and Alzheimer’s Disease

2007

We evaluated the relationship between motor and neuropsychological deficits in subjects affected by amnestic Mild Cognitive Impairment (aMCI) and early Alzheimer’s Disease (AD). Kinematics of goal-directed movement of aMCI and AD subjects were compared to those of age-matched control subjects. AD showed a slowing down of motor performance compared to aMCI and controls. No relationships were found between motor and cognitive performances in both AD and aMCI. Our results suggest that the different motor behaviour between AD and aMCI cannot be related to memory deficits, probably reflecting the initial degeneration of parietal-frontal circuits for movement planning. The onset of motor dysfunct…

Malemedicine.medical_specialtyMild Cognitive ImpairmentMotor dysfunctionneuropsychologyNeurosciences. Biological psychiatry. NeuropsychiatryDiseaseAudiologyNeuropsychological TestsMotor behaviourSeverity of Illness Indexbehavioral disciplines and activitiesAlzheimer Diseasemental disordersmedicineReaction TimeHumansBiomechanicsClinical NoteAlzheimer’s DiseaseCognitive impairmentalzheimer's disease mild cognitive impairment kinematicsAgedDemographypointingMovement DisordersNeuropsychologyCognitionGeneral MedicineControl subjectsBiomechanical PhenomenaSeverity of Illness Index; Humans; Alzheimer Disease; Aged; Mental Recall; Cognition Disorders; Demography; Movement Disorders; Neuropsychological Tests; Amnesia; Biomechanics; Female; Male; Reaction TimeNeuropsychology and Physiological PsychologyNeurologykinematicsMental RecallSettore MED/26 - NeurologiaFemaleNeurology (clinical)AmnesiaPsychologyCognition DisordersNeuroscienceMovement planningRC321-571Behavioural Neurology
researchProduct

The neuropsychiatric profile of Parkinson's disease subjects with and without mild cognitive impairment

2012

Neuropsychiatric symptoms (NPS) are common clinical features of Parkinson's disease (PD). However, NPS profiles in PD subjects with mild cognitive impairment (MCI) have scarcely been investigated. We aimed to describe the NPS profiles of non-demented PD subjects with and without MCI. A total of 410 non-demented PD subjects were included. Of these, 164 were cognitively normal PD subjects (PD-cn), 142 PD had amnestic MCI (PD-aMCI), and 104 had PD with non-amnestic MCI (PD-naMCI). NPS were evaluated in accordance with the Neuropsychiatric Inventory (NPI). PD-aMCI subjects revealed the highest NPS burden, followed by PD-naMCI and then PD-cn. Overall, the most common NPS in PD-MCI were in order:…

Malemedicine.medical_specialtyNeurologyParkinson's diseaseNeuropsychological TestsIrritabilitySeverity of Illness Indexbehavioral disciplines and activitiesCognitionInternal medicinemental disordersSeverity of illnessmedicineHumansCognitive DysfunctionApathyParkinson’s disease Cognitive impairment Neuropsychiatric symptoms EpidemiologyBiological PsychiatryDepression (differential diagnoses)AgedSleep disordertechnology industry and agricultureParkinson DiseaseMiddle Agedmedicine.diseasePsychiatry and Mental healthNeurologyPhysical therapyAnxietyFemaleSettore MED/26 - NeurologiaAmnesiaNeurology (clinical)medicine.symptomPsychology
researchProduct

Misidentification Delusions : prevalence in different types of dementia and validation of a structured Questionnaire

2016

International audience; Misidentification delusions (MDs) are considered relatively rare psychopathologic phenomena that may occur within the context of psychiatric or neurological conditions. The purpose of this study was to assess the prevalence of MD in different types of dementia, correlate the presence of MD with demographic and clinical variables, and validate a specific questionnaire. We examined 146 subjects with Alzheimer disease, 21 with Lewy body dementia, 6 with frontotemporal dementia, and 13 with vascular dementia (subcortical type), who were consecutively enrolled in the study from 2 Memory Clinics. Patients had a mean age of 78.7±6.4 years and an Mini-Mental State Examinatio…

Malemedicine.medical_specialtyhome misidentificationReduplicative paramnesia[ SCCO.PSYC ] Cognitive science/PsychologyContext (language use)reduplicative paramnesiaDelusions[ SDV.NEU.SC ] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/Cognitive Sciences03 medical and health sciences0302 clinical medicineDelusionSurveys and QuestionnairesPrevalenceHumansMedicineDementiaVascular dementiaPsychiatryAgedPsychiatric Status Rating ScalesLewy bodybusiness.industry[SCCO.NEUR]Cognitive science/Neuroscience[SDV.NEU.SC]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/Cognitive Sciencesmedicine.disease030227 psychiatrymisidentification delusionsPsychiatry and Mental healthClinical PsychologyCapgras syndrome[ SCCO.NEUR ] Cognitive science/Neuroscience[SCCO.PSYC]Cognitive science/PsychologyDementiaFemaleGeriatrics and GerontologyAlzheimer's diseasemedicine.symptomAlzheimer diseaseLewy body dementiabusinessGerontology030217 neurology & neurosurgeryClinical psychologyFrontotemporal dementia
researchProduct

When the amnestic mild cognitive impairment disappears: characterisation of the memory profile

2009

BACKGROUND/OBJECTIVES: Subjects affected by mild cognitive impairment (MCI) may improve during the observation period. This is the first study investigating qualitative features of memory deficits in subjects affected by reversible MCI [reversible cognitive impairment (RCI)]. METHODS: Baseline cognitive and memory performances of 18 subjects affected by amnestic MCI who had normalized cognitive performances at follow-ups were compared with those of 76 amnestic MCI subjects who still showed impaired cognitive performances at the 24-month follow-up (MCI) and with those of a group of 87 matched control subjects (normal controls). RESULTS: Compared with normal controls the memory deficit in the…

MalememorianeuropsychologyAudiologyNeuropsychological TestsAlzheimer diseaseMemoryMild cognitive impairmentNeuropsychologyPreclinical dementiadeterioramento cognitivo lieveLong-term memoryCognitive disorderNeuropsychologypreclinical dementiaCognitionGeneral MedicinePsychiatry and Mental healthNeuropsychology and Physiological PsychologyMemory Short-TermDisease ProgressionFemaleSettore MED/26 - Neurologiamedicine.symptomAlzheimer's diseasePsychologymedicine.medical_specialtyCognitive NeuroscienceAmnesiaHumans; Alzheimer Disease; Disease Progression; Aged; Mental Recall; Cognition Disorders; Memory; Memory Short-Term; Recognition (Psychology); Psychomotor Performance; Follow-Up Studies; Neuropsychological Tests; Amnesia; Female; MaleRecognition (Psychology)M-PSI/02 - PSICOBIOLOGIA E PSICOLOGIA FISIOLOGICAbehavioral disciplines and activitiesmild cognitive impairmentAlzheimer DiseaseMemorymental disordersNeuropsychologiamedicineHumansMemory disorderAgedMED/26 - NEUROLOGIARecognition Psychologymedicine.diseaseMCInervous system diseasesShort-TermMental Recallmild cognitive impairment; neuropsychology; memory; preclinical dementia; Alzheimer diseaseAmnesiaMED/09 - MEDICINA INTERNACognition Disordershuman activitiesNeurosciencePsychomotor PerformanceFollow-Up Studies
researchProduct

The contribution of acetylcholine and dopamine to subprocesses of visual working memory--what patients with amnestic mild cognitive impairment and Pa…

2014

Attentional selection, i.e. filtering out of irrelevant sensory input and information storage are two crucial components of working memory (WM). It has been proposed that the two processes are mediated by different neurotransmitters, namely acetylcholine for attentional selection and dopamine for memory storage. However, this hypothesis has been challenged by others, who for example linked a lack in dopamine levels in the brain to filtering deficits. Here we tested the above mentioned hypothesis in two patient cohorts which either served as a proxy for a cholinergic or a dopaminergic deficit. The first group comprised 18 patients with amnestic mild cognitive impairment (aMCI), the second 22…

Malephysiopathology [Cognitive Dysfunction]Parkinson's diseaseCognitive NeuroscienceDopamineModels NeurologicalExperimental and Cognitive Psychologyphysiopathology [Brain]Neuropsychological TestsCohort StudiesBehavioral Neurosciencechemistry.chemical_compoundDopaminemedicineHumansAttentionCognitive Dysfunctionddc:610metabolism [Dopamine]NeurotransmitterAgedWorking memoryDopaminergicBrainCognitionParkinson Diseasephysiopathology [Amnesia]Middle Agedphysiology [Visual Perception]medicine.diseaseAcetylcholineMemory Short-Termchemistryphysiology [Memory Short-Term]physiology [Attention]Visual PerceptionCholinergicFemalephysiopathology [Parkinson Disease]AmnesiaPsychologyNeurosciencemetabolism [Acetylcholine]Acetylcholinemedicine.drugNeuropsychologia
researchProduct

Neonatal representation of odour objects: distinct memories of the whole and its parts

2014

Extraction of relevant information from highly complex environments is a prerequisite to survival. Within odour mixtures, such information is contained in the odours of specific elements or in the mixture configuration perceived as a whole unique odour. For instance, an AB mixture of the element A (ethyl isobutyrate) and the element B (ethyl maltol) generates a configural AB percept in humans and apparently in another species, the rabbit. Here, we examined whether the memory of such a configuration is distinct from the memory of the individual odorants. Taking advantage of the newborn rabbit's ability to learn odour mixtures, we combined behavioural and pharmacological tools to specifically…

Olfactory perceptionMalerepresentationAmnesiaComplex MixturesGeneral Biochemistry Genetics and Molecular Biologyoryctolagus cuniculusodour mixturememorychemistry.chemical_compoundnewbornConditioning PsychologicalmedicineAnimals[ SDV.BDD ] Life Sciences [q-bio]/Development Biologyconfigural perception[SDV.BDD]Life Sciences [q-bio]/Development BiologyResearch ArticlesGeneral Environmental ScienceCommunicationAldehydesGeneral Immunology and Microbiologybusiness.industryEthyl maltolRepresentation (systemics)General MedicineOlfactory PerceptionchemistryAnimals NewbornPyronesOdorantsConditioningFemaleAmnesiaRabbitsPerceptmedicine.symptomPropionatesGeneral Agricultural and Biological SciencesBiological systemPsychologybusinessRelevant information
researchProduct